CN113774127B - 血清细胞外囊泡miR-503-5p在制备2型糖尿病发病的诊断试剂盒中的应用 - Google Patents
血清细胞外囊泡miR-503-5p在制备2型糖尿病发病的诊断试剂盒中的应用 Download PDFInfo
- Publication number
- CN113774127B CN113774127B CN202111119754.5A CN202111119754A CN113774127B CN 113774127 B CN113774127 B CN 113774127B CN 202111119754 A CN202111119754 A CN 202111119754A CN 113774127 B CN113774127 B CN 113774127B
- Authority
- CN
- China
- Prior art keywords
- mir
- kit
- serum
- hsa
- extracellular vesicle
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6844—Nucleic acid amplification reactions
- C12Q1/6851—Quantitative amplification
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/112—Disease subtyping, staging or classification
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/154—Methylation markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/178—Oligonucleotides characterized by their use miRNA, siRNA or ncRNA
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Analytical Chemistry (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Physics & Mathematics (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Pathology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Description
编号 | 性别 | 年龄 | BMI(kg/m<sup>2</sup>) | 空腹血糖(mg/dL) | 糖尿病史 |
1 | 男 | 37 | 20.6 | 96.84 | 无 |
2 | 女 | 29 | 22.5 | 96.12 | 无 |
3 | 女 | 39 | 20.4 | 93.78 | 无 |
4 | 女 | 21 | 20.3 | 87.3 | 无 |
5 | 男 | 24 | 23.1 | 87.12 | 无 |
6 | 男 | 21 | 18.7 | 94.86 | 无 |
7 | 女 | 21 | 19.1 | 80.46 | 无 |
8 | 女 | 24 | 19.1 | 94.68 | 无 |
9 | 女 | 28 | 19.3 | 82.08 | 无 |
10 | 女 | 28 | 19.4 | 84.6 | 无 |
11 | 男 | 30 | 19.4 | 89.46 | 无 |
12 | 男 | 29 | 19.5 | 95.22 | 无 |
13 | 女 | 31 | 19.6 | 85.68 | 无 |
14 | 男 | 28 | 19.7 | 88.92 | 无 |
15 | 男 | 32 | 20.3 | 93.06 | 无 |
编号 | 性别 | 年龄 | BMI(kg/m<sup>2</sup>) | 空腹血糖(mg/dL) | 糖尿病史 |
1 | 女 | 65 | 20.6 | 115.56 | 有 |
2 | 男 | 80 | 24.2 | 114.3 | 有 |
3 | 男 | 83 | 23.9 | 159.66 | 有 |
4 | 男 | 68 | 26.2 | 147.96 | 有 |
5 | 女 | 73 | 29.8 | 111.96 | 有 |
6 | 女 | 65 | 25.3 | 140.4 | 有 |
7 | 男 | 67 | 20.1 | 154.98 | 有 |
8 | 女 | 67 | 25.9 | 207.18 | 有 |
9 | 女 | 68 | 27.4 | 124.74 | 有 |
10 | 女 | 68 | 28.4 | 228.24 | 有 |
11 | 女 | 76 | 22.4 | 154.08 | 有 |
12 | 男 | 79 | 23.4 | 239.22 | 有 |
13 | 女 | 80 | 26.4 | 153.54 | 有 |
14 | 男 | 81 | 19.4 | 179.64 | 有 |
15 | 女 | 83 | 28.4 | 252.36 | 有 |
16 | 男 | 84 | 23.1 | 176.4 | 有 |
试剂 | 体积(10μl体系) |
5×逆转录缓冲液 | 2μl |
dNTP | 2μl |
引物 | 0.5μl |
RNA酶抑制剂 | 0.5μl |
逆转录酶 | 0.5μl |
RNA | 1μl |
DEPC水 | 3.5μl |
Claims (3)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202111119754.5A CN113774127B (zh) | 2021-09-24 | 2021-09-24 | 血清细胞外囊泡miR-503-5p在制备2型糖尿病发病的诊断试剂盒中的应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202111119754.5A CN113774127B (zh) | 2021-09-24 | 2021-09-24 | 血清细胞外囊泡miR-503-5p在制备2型糖尿病发病的诊断试剂盒中的应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN113774127A CN113774127A (zh) | 2021-12-10 |
CN113774127B true CN113774127B (zh) | 2022-06-24 |
Family
ID=78853023
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202111119754.5A Active CN113774127B (zh) | 2021-09-24 | 2021-09-24 | 血清细胞外囊泡miR-503-5p在制备2型糖尿病发病的诊断试剂盒中的应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN113774127B (zh) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN114807343B (zh) * | 2022-03-29 | 2023-10-31 | 南京医科大学 | 检测胰岛β细胞去分化的标志物的用途 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103025890A (zh) * | 2010-04-06 | 2013-04-03 | 卡里斯生命科学卢森堡控股 | 疾病的循环生物标志物 |
WO2018125019A2 (en) * | 2016-12-30 | 2018-07-05 | Istanbul Üni̇versi̇tesi̇ | Use of some mirnas for the diagnosis and treatment of diseases associated with insulin |
CN110295227A (zh) * | 2019-06-11 | 2019-10-01 | 华中科技大学同济医学院附属同济医院 | 基于hsa-miR-320a的糖尿病早期预警和/或诊断试剂盒的制备方法 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20160145612A1 (en) * | 2013-03-06 | 2016-05-26 | Royal College Of Surgeons In Ireland | Diagnosis and treatment of metabolic disorders |
-
2021
- 2021-09-24 CN CN202111119754.5A patent/CN113774127B/zh active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103025890A (zh) * | 2010-04-06 | 2013-04-03 | 卡里斯生命科学卢森堡控股 | 疾病的循环生物标志物 |
WO2018125019A2 (en) * | 2016-12-30 | 2018-07-05 | Istanbul Üni̇versi̇tesi̇ | Use of some mirnas for the diagnosis and treatment of diseases associated with insulin |
CN110295227A (zh) * | 2019-06-11 | 2019-10-01 | 华中科技大学同济医学院附属同济医院 | 基于hsa-miR-320a的糖尿病早期预警和/或诊断试剂盒的制备方法 |
Non-Patent Citations (1)
Title |
---|
MicroRNA‑503‑5p improves carotid artery stenosis by inhibiting the proliferation of vascular smooth muscle cells;ZHIYUAN YAN 等;《EXPERIMENTAL AND THERAPEUTIC MEDICINE》;20201231;第20卷(第5期);第1-6页 * |
Also Published As
Publication number | Publication date |
---|---|
CN113774127A (zh) | 2021-12-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Wang et al. | Circulating microRNAs have a sex-specific association with metabolic syndrome | |
EP2406402B1 (en) | Method to assess human allograft status from microrna expression levels | |
Eliasson et al. | Micro (RNA) management and mismanagement of the islet | |
US20190153446A1 (en) | Mir-149-3p and method for treating metabolic disease using the same | |
Floris et al. | MiRNA analysis by quantitative PCR in preterm human breast milk reveals daily fluctuations of hsa-miR-16-5p | |
CN106148537B (zh) | 一种与2型糖尿病相关的血清或血浆miRNA标志物及其应用 | |
Santamaria-Martos et al. | Comparative and functional analysis of plasma membrane-derived extracellular vesicles from obese vs. nonobese women | |
Jiang et al. | β-Sitosterol regulated microRNAs in endothelial cells against an oxidized low-density lipoprotein | |
Jiao et al. | MicroRNA-130a expression is decreased in Xinjiang Uygur patients with type 2 diabetes mellitus | |
CN113774127B (zh) | 血清细胞外囊泡miR-503-5p在制备2型糖尿病发病的诊断试剂盒中的应用 | |
CN107653315A (zh) | lncRNAs作为活动性肺结核病特异性标志物的应用 | |
Christ et al. | Smooth-muscle–specific gene transfer with the human Maxi-K channel improves erectile function and enhances sexual behavior in atherosclerotic cynomolgus monkeys | |
CN107557472B (zh) | 胶质瘤诊断标志物circ9:135881633|135883078及应用 | |
de Candia et al. | The circulating microRNome demonstrates distinct lymphocyte subset‐dependent signatures | |
CN107858355B (zh) | 一种非酒精性脂肪肝的miRNA标志物及其应用 | |
CN105039536A (zh) | mo-miR-877在制备肾毒性生物标志物中的用途 | |
CN106119348B (zh) | 一种以非编码lnc‑CXCL1及编码基因cxcl1组合为检测或诊断筛查标志物的重症肌无力检测试剂盒及应用 | |
Liu et al. | Adipose‐derived miRNAs as potential biomarkers for predicting adulthood obesity and its complications: A systematic review and bioinformatic analysis | |
CN107604076A (zh) | 胶质瘤诊断标志物Circ6:4891713|4892379及应用 | |
US20230088599A1 (en) | Mir-149-3p and method for treating metabolic disease using the same | |
Bai et al. | The mediating role of plasma microRNAs in the association of phthalates exposure with arterial stiffness: A panel study | |
Barseem et al. | Dysregulated Circulating micro RNAs Markers: New Evidence into Expression Pattern in Children with T1D among Egyptian Population | |
CN107586846A (zh) | 胶质瘤诊断标志物Circ3:129880309|129880559及应用 | |
CN108315417A (zh) | 通过血液中miR-124-3p和GATA3-AS1联合检测胃癌的试剂盒 | |
CN107586843A (zh) | 胶质瘤诊断标志物circ7:100812747|100813208及应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
CB03 | Change of inventor or designer information |
Inventor after: Tang Wei Inventor after: Liu Kerong Inventor after: Zhu Yunxia Inventor after: Xiao Xiao Inventor after: Han Xiao Inventor after: Zhou Yuncai Inventor after: Bai Rongjie Inventor after: Chang Xiaoai Inventor before: Tang Wei Inventor before: Zhou Yuncai Inventor before: Zhu Yunxia Inventor before: Xiao Xiao Inventor before: Han Xiao Inventor before: Liu Kerong Inventor before: Bai Rongjie Inventor before: Chang Xiaoai |
|
CB03 | Change of inventor or designer information |